Dr. Reddy's Laboratories

NYSE
RDY
Stock
Yield per half year: +4.59%
Dividend yield: 2.72%
Sector: Healthcare

Dr. Reddy's Laboratories

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
0.2151 27.75 -99.22% 8.49 -97.47%
P/S 0.0374 4.09 -99.09%
P/BV 0.0365 10.31 -99.65%
P/FCF 1.01 36.17 -97.2%
Ev/Ebitda 10.06 18.11 -44.45%
Ev/S 2.99 4.44 -32.76%
Ev/FCF 80.84 45.44 77.91%
E/P 4.65 0.2325 1899.68%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
8/10
29.7 21.85 35.93% 27.93 +6.31%
ROE 16.96 -73.93 -122.94%
ROA 11.47 6.84 67.72%
ROIC 20.74 21.56 -3.77%
ROS 17.37 11.07 56.84%
ROCE 23.61 83.13 -71.6%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.4838 2.68 -81.93% 0.4441 +8.94%
Nеt Debt/Ebitda 0.3322 2.84 -88.28%
Debt/Ratio 0.0949 0.2925 -67.57%
Debt/Equity 0.4622 14.82 -96.88%
Debt/Net Income 0.8271 5.09 -83.77%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
6.8/10
2.72 1.35 101.46% 2.5 +8.91%
Number of years of dividend growth 1 6.36 -84.27%
DSI 0.8571 0.7374 16.24%
Average dividend growth -71.67 -11.88 503.38%
Average percentage for 5 years 2.5 1.31 91.09%
Average percentage for payments 134296.02 42.44 316370.51%
Difference from average difference in sector 1.37

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
8/10
71.59 511.13 -85.99%
Growth impulse Ebitda in 5 years 97.86 488.51 -79.97%
Growth impulse Net Income in 5 years 228.02 282.15 -19.18%
Growth impulse FCF in 5 years -48.02 265.63 -118.08%
Growth impulse EPS in 5 years 4244.51 244.27 1637.63%
IP Score
7.21/10

Similar companies

Eli Lilly and Company

PFIZER

Johnson & Johnson

Zoetis

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription